Archive for January 7th, 2009

Chain Drug Review - Lilly Ups Support for Evista

Wednesday, January 7th, 2009

INDIANAPOLIS — Eli Lilly and Co. is providing additional support for Evista, its osteoporosis preventive, by reorganizing its pharmaceutical sales force.
Evista, known generically as raloxifene hydrochloride, is marketed for the prevention of osteoporosis in postmenopausal women.